10-K Filing

EDWARDS LIFESCIENCES CORP CIK: 1099800 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001099800-24-000004`
Period End Date	20231231
Filing Date	20240212
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	ew-20231231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 100 Income Statement 63 Cash Flow Statement 122 Stockholders Equity 32 Comprehensive Income 27

Balance Sheet 100 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$8.30M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$7.90M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.14B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$769.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$862.80M	USD	Point-in-time
Preferred stock, authorized shares (in shares)	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock, authorized shares (in shares)	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments (Note 7)	`ShortTermInvestments`	$500.50M	USD	Point-in-time
Short-term investments (Note 7)	`ShortTermInvestments`	$446.30M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Accounts receivable, net of allowances of $8.3 and $7.9, respectively	`AccountsReceivableNetCurrent`	$775.10M	USD	Point-in-time
Accounts receivable, net of allowances of $8.3 and $7.9, respectively	`AccountsReceivableNetCurrent`	$643.00M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.05B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.05B	shares	Point-in-time
Other receivables	`OtherReceivables`	$56.10M	USD	Point-in-time
Other receivables	`OtherReceivables`	$61.80M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	650.50M	shares	Point-in-time
Inventories (Note 5)	`InventoryNet`	$1.17B	USD	Point-in-time
Inventories (Note 5)	`InventoryNet`	$875.50M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	646.30M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$146.80M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$110.00M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	601.10M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	608.30M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	38.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$195.90M	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	49.40M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$239.30M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.04B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.10B	USD	Point-in-time
Long-term investments (Note 7)	`LongTermInvestments`	$1.24B	USD	Point-in-time
Long-term investments (Note 7)	`LongTermInvestments`	$583.90M	USD	Point-in-time
Property, plant, and equipment, net (Note 5)	`PropertyPlantAndEquipmentNet`	$1.63B	USD	Point-in-time
Property, plant, and equipment, net (Note 5)	`PropertyPlantAndEquipmentNet`	$1.75B	USD	Point-in-time
Operating lease right-of-use assets (Note 6)	`OperatingLeaseRightOfUseAsset`	$94.00M	USD	Point-in-time
Operating lease right-of-use assets (Note 6)	`OperatingLeaseRightOfUseAsset`	$92.30M	USD	Point-in-time
Goodwill (Note 10)	`Goodwill`	$1.25B	USD	Point-in-time
Goodwill (Note 10)	`Goodwill`	$1.16B	USD	Point-in-time
Goodwill (Note 10)	`Goodwill`	$1.17B	USD	Point-in-time
Other intangible assets, net (Note 10)	`IntangibleAssetsNetExcludingGoodwill`	$428.40M	USD	Point-in-time
Other intangible assets, net (Note 10)	`IntangibleAssetsNetExcludingGoodwill`	$285.20M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$754.60M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$484.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$299.10M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$463.70M	USD	Point-in-time
Total assets	`Assets`	$8.29B	USD	Point-in-time
Total assets	`Assets`	$9.36B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$201.40M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$201.90M	USD	Point-in-time
Accrued and other liabilities (Note 5)	`AccruedAndOtherLiabilitiesCurrent`	$969.10M	USD	Point-in-time
Accrued and other liabilities (Note 5)	`AccruedAndOtherLiabilitiesCurrent`	$795.00M	USD	Point-in-time
Operating lease liabilities (Note 6)	`OperatingLeaseLiabilityCurrent`	$25.50M	USD	Point-in-time
Operating lease liabilities (Note 6)	`OperatingLeaseLiabilityCurrent`	$24.90M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.20B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.02B	USD	Point-in-time
Long-term debt (Note 11)	`LongTermDebtNoncurrent`	$597.00M	USD	Point-in-time
Long-term debt (Note 11)	`LongTermDebtNoncurrent`	$596.30M	USD	Point-in-time
Contingent consideration liabilities (Note 12)	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	-	USD	Point-in-time
Contingent consideration liabilities (Note 12)	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$26.20M	USD	Point-in-time
Taxes payable (Note 18)	`TaxesPayableCurrentAndNoncurrent`	$143.40M	USD	Point-in-time
Taxes payable (Note 18)	`TaxesPayableCurrentAndNoncurrent`	$80.60M	USD	Point-in-time
Operating lease liabilities (Note 6)	`OperatingLeaseLiabilityNoncurrent`	$69.50M	USD	Point-in-time
Operating lease liabilities (Note 6)	`OperatingLeaseLiabilityNoncurrent`	$73.00M	USD	Point-in-time
Uncertain tax positions (Note 18)	`LiabilityForUncertainTaxPositionsNoncurrent`	$267.50M	USD	Point-in-time
Uncertain tax positions (Note 18)	`LiabilityForUncertainTaxPositionsNoncurrent`	$339.30M	USD	Point-in-time
Litigation settlement accrual (Note 3)	`LitigationReserveNoncurrent`	$143.00M	USD	Point-in-time
Litigation settlement accrual (Note 3)	`LitigationReserveNoncurrent`	$94.20M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$217.50M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$264.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$2.49B	USD	Point-in-time
Total liabilities	`Liabilities`	$2.64B	USD	Point-in-time
Commitments and contingencies (Notes 6, 11, and 19)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 6, 11, and 19)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $1.00 par value, 1,050.0 shares authorized, 650.5 and 646.3 shares issued, and 601.1 and 608.3 shares outstanding, respectively	`CommonStockValue`	$646.30M	USD	Point-in-time
Common stock, $1.00 par value, 1,050.0 shares authorized, 650.5 and 646.3 shares issued, and 601.1 and 608.3 shares outstanding, respectively	`CommonStockValue`	$650.50M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$2.27B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.97B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$8.99B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$7.59B	USD	Point-in-time
Accumulated other comprehensive loss (Note 16)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-254.90M	USD	Point-in-time
Accumulated other comprehensive loss (Note 16)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-242.80M	USD	Point-in-time
Treasury stock, at cost, 49.4 and 38.0 shares, respectively	`TreasuryStockCommonValue`	$4.14B	USD	Point-in-time
Treasury stock, at cost, 49.4 and 38.0 shares, respectively	`TreasuryStockCommonValue`	$5.02B	USD	Point-in-time
Total Edwards Lifesciences Corporation stockholders' equity	`StockholdersEquity`	$5.81B	USD	Point-in-time
Total Edwards Lifesciences Corporation stockholders' equity	`StockholdersEquity`	$6.65B	USD	Point-in-time
Noncontrolling interest (Note 9)	`MinorityInterest`	$69.40M	USD	Point-in-time
Noncontrolling interest (Note 9)	`MinorityInterest`	-	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.72B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.57B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.84B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.81B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$8.29B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$9.36B	USD	Point-in-time

Income Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$5.38B	USD	Annual
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$5.23B	USD	Annual
Net sales	`RevenueFromContractWithCustomerExcludingAssessedTax`	$6.00B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$1.25B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$1.08B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$1.38B	USD	Annual
Gross profit	`GrossProfit`	$4.30B	USD	Annual
Gross profit	`GrossProfit`	$3.98B	USD	Annual
Gross profit	`GrossProfit`	$4.62B	USD	Annual
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.82B	USD	Annual
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.57B	USD	Annual
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.49B	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	$1.07B	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	$903.10M	USD	Annual
Research and development expenses	`ResearchAndDevelopmentExpense`	$945.20M	USD	Annual
Intellectual property agreement and litigation expense (Note 3)	`LitigationSettlementsAndLegalCosts`	$15.80M	USD	Annual
Intellectual property agreement and litigation expense (Note 3)	`LitigationSettlementsAndLegalCosts`	$203.50M	USD	Annual
Intellectual property agreement and litigation expense (Note 3)	`LitigationSettlementsAndLegalCosts`	$20.60M	USD	Annual
Change in fair value of contingent consideration liabilities (Note 12)	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-124.10M	USD	Annual
Change in fair value of contingent consideration liabilities (Note 12)	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-26.20M	USD	Annual
Change in fair value of contingent consideration liabilities (Note 12)	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-35.80M	USD	Annual
Special charge and separation costs (Note 4)	`OtherNonrecurringIncomeExpense`	$17.20M	USD	Annual
Special charge and separation costs (Note 4)	`OtherNonrecurringIncomeExpense`	$60.70M	USD	Annual
Special charge and separation costs (Note 4)	`OtherNonrecurringIncomeExpense`	-	USD	Annual
Operating income	`OperatingIncomeLoss`	$1.75B	USD	Annual
Operating income	`OperatingIncomeLoss`	$1.53B	USD	Annual
Operating income	`OperatingIncomeLoss`	$1.69B	USD	Annual
Interest expense	`InterestExpense`	$18.40M	USD	Annual
Interest expense	`InterestExpense`	$19.20M	USD	Annual
Interest expense	`InterestExpense`	$17.60M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$35.50M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$67.20M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$17.40M	USD	Annual
Other income, net (Note 17)	`OtherNonoperatingIncomeExpense`	$2.60M	USD	Annual
Other income, net (Note 17)	`OtherNonoperatingIncomeExpense`	$14.40M	USD	Annual
Other income, net (Note 17)	`OtherNonoperatingIncomeExpense`	$12.70M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.77B	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.60B	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.70B	USD	Annual
Provision for income taxes (Note 18)	`IncomeTaxExpenseBenefit`	$198.90M	USD	Annual
Provision for income taxes (Note 18)	`IncomeTaxExpenseBenefit`	$245.50M	USD	Annual
Provision for income taxes (Note 18)	`IncomeTaxExpenseBenefit`	$198.70M	USD	Annual
Net income	`ProfitLoss`	$1.52B	USD	Annual
Net income	`ProfitLoss`	$1.50B	USD	Annual
Net income	`ProfitLoss`	$1.40B	USD	Annual
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.00M	USD	Annual
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Net income attributable to Edwards Lifesciences Corporation.	`NetIncomeLoss`	$1.40B	USD	Annual
Net income attributable to Edwards Lifesciences Corporation.	`NetIncomeLoss`	$1.50B	USD	Annual
Net income attributable to Edwards Lifesciences Corporation.	`NetIncomeLoss`	$1.52B	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.31	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.46	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.41	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.30	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.38	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.44	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	623.30M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	606.70M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	619.00M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	609.40M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	631.20M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	624.20M	shares	Annual

Cash Flow Statement 122 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$1.52B	USD	Annual
Net income	`ProfitLoss`	$1.50B	USD	Annual
Net income	`ProfitLoss`	$1.40B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$144.90M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$139.60M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$134.80M	USD	Annual
Non-cash operating lease cost	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$28.20M	USD	Annual
Non-cash operating lease cost	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$27.20M	USD	Annual
Non-cash operating lease cost	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$28.50M	USD	Annual
Stock-based compensation (Notes 2 and 15)	`ShareBasedCompensation`	$109.30M	USD	Annual
Stock-based compensation (Notes 2 and 15)	`ShareBasedCompensation`	$126.80M	USD	Annual
Stock-based compensation (Notes 2 and 15)	`ShareBasedCompensation`	$139.40M	USD	Annual
Impairment charges (Note 4)	`AssetImpairmentCharges`	$4.00M	USD	Annual
Impairment charges (Note 4)	`AssetImpairmentCharges`	$55.10M	USD	Annual
Impairment charges (Note 4)	`AssetImpairmentCharges`	-	USD	Annual
Change in fair value of contingent consideration liabilities (Note 12)	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-35.80M	USD	Annual
Change in fair value of contingent consideration liabilities (Note 12)	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-124.10M	USD	Annual
Change in fair value of contingent consideration liabilities (Note 12)	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-26.20M	USD	Annual
Loss (gain) on investments, net	`GainLossOnInvestments`	$36.80M	USD	Annual
Loss (gain) on investments, net	`GainLossOnInvestments`	$-51.50M	USD	Annual
Loss (gain) on investments, net	`GainLossOnInvestments`	$-100.00K	USD	Annual
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$41.40M	USD	Annual
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$272.10M	USD	Annual
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$254.50M	USD	Annual
Other	`OtherNoncashIncomeExpense`	$-7.80M	USD	Annual
Other	`OtherNoncashIncomeExpense`	$-9.40M	USD	Annual
Other	`OtherNoncashIncomeExpense`	$-8.40M	USD	Annual
Accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$141.20M	USD	Annual
Accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$91.10M	USD	Annual
Accounts and other receivables, net	`IncreaseDecreaseInAccountsAndOtherReceivables`	$84.10M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$289.00M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$213.40M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$-19.00M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$81.80M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-100.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-7.90M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$195.20M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-21.40M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$146.00M	USD	Annual
Intellectual property agreement accrual	`IncreaseDecreaseInLegalSettlementAccrual`	$-45.00M	USD	Annual
Intellectual property agreement accrual	`IncreaseDecreaseInLegalSettlementAccrual`	$-33.00M	USD	Annual
Intellectual property agreement accrual	`IncreaseDecreaseInLegalSettlementAccrual`	$-29.20M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-5.80M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$62.00M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-5.60M	USD	Annual
Long-term prepaid royalties (Note 3)	`IncreaseDecreaseInPrepaidRoyalties`	-	USD	Annual
Long-term prepaid royalties (Note 3)	`IncreaseDecreaseInPrepaidRoyalties`	$109.90M	USD	Annual
Long-term prepaid royalties (Note 3)	`IncreaseDecreaseInPrepaidRoyalties`	-	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$18.50M	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$11.60M	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingCapitalNet`	$52.00M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$895.80M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.22B	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.73B	USD	Annual
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$244.60M	USD	Annual
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$325.80M	USD	Annual
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$253.00M	USD	Annual
Purchases of held-to-maturity investments (Note 7)	`PaymentsToAcquireHeldToMaturitySecurities`	$66.40M	USD	Annual
Purchases of held-to-maturity investments (Note 7)	`PaymentsToAcquireHeldToMaturitySecurities`	$250.00M	USD	Annual
Purchases of held-to-maturity investments (Note 7)	`PaymentsToAcquireHeldToMaturitySecurities`	$353.50M	USD	Annual
Proceeds from sales and maturities of held-to-maturity investments (Note 7)	`ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities`	$97.90M	USD	Annual
Proceeds from sales and maturities of held-to-maturity investments (Note 7)	`ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities`	$419.50M	USD	Annual
Proceeds from sales and maturities of held-to-maturity investments (Note 7)	`ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities`	$138.00M	USD	Annual
Purchases of available-for-sale investments (Note 7)	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$1.63B	USD	Annual
Purchases of available-for-sale investments (Note 7)	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$315.80M	USD	Annual
Purchases of available-for-sale investments (Note 7)	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$9.10M	USD	Annual
Proceeds from sales and maturities of available-for-sale investments (Note 7)	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$939.60M	USD	Annual
Proceeds from sales and maturities of available-for-sale investments (Note 7)	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$391.20M	USD	Annual
Proceeds from sales and maturities of available-for-sale investments (Note 7)	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$617.90M	USD	Annual
Business combination, net of cash (Note 9)	`PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions`	-	USD	Annual
Business combination, net of cash (Note 9)	`PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions`	-	USD	Annual
Business combination, net of cash (Note 9)	`PaymentsToAcquireBusinessesNetOfCashAcquiredExcludingOptions`	$95.20M	USD	Annual
Payments for acquisition options (Note 8)	`OtherPaymentsToAcquireBusinesses`	$109.60M	USD	Annual
Payments for acquisition options (Note 8)	`OtherPaymentsToAcquireBusinesses`	$30.00M	USD	Annual
Payments for acquisition options (Note 8)	`OtherPaymentsToAcquireBusinesses`	$13.10M	USD	Annual
Issuances of notes receivable	`PaymentsToAcquireReceivables`	$62.50M	USD	Annual
Issuances of notes receivable	`PaymentsToAcquireReceivables`	$5.10M	USD	Annual
Issuances of notes receivable	`PaymentsToAcquireReceivables`	$52.30M	USD	Annual
Collections of notes receivable	`ProceedsFromCollectionOfNotesReceivable`	-	USD	Annual
Collections of notes receivable	`ProceedsFromCollectionOfNotesReceivable`	$20.00M	USD	Annual
Collections of notes receivable	`ProceedsFromCollectionOfNotesReceivable`	$18.00M	USD	Annual
Investments in intangible assets	`PaymentsToAcquireIntangibleAssets`	$20.20M	USD	Annual
Investments in intangible assets	`PaymentsToAcquireIntangibleAssets`	$13.30M	USD	Annual
Investments in intangible assets	`PaymentsToAcquireIntangibleAssets`	$4.00M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$12.50M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$28.80M	USD	Annual
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$44.40M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$173.80M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$252.30M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.72B	USD	Annual
Proceeds from issuance of debt	`ProceedsFromIssuanceOfLongTermDebt`	$5.20M	USD	Annual
Proceeds from issuance of debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Proceeds from issuance of debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Payments on debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$7.00M	USD	Annual
Payments on debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$200.00K	USD	Annual
Payments on debt and finance lease obligations	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$300.00K	USD	Annual
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$1.73B	USD	Annual
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$512.80M	USD	Annual
Purchases of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$879.60M	USD	Annual
Proceeds from stock plans	`ProceedsFromStockPlans`	$169.90M	USD	Annual
Proceeds from stock plans	`ProceedsFromStockPlans`	$146.40M	USD	Annual
Proceeds from stock plans	`ProceedsFromStockPlans`	$158.60M	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.00M	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-300.00K	USD	Annual
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-3.60M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-711.00M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-356.30M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.58B	USD	Annual
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.90M	USD	Annual
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.80M	USD	Annual
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.20M	USD	Annual
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$375.40M	USD	Annual
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-332.80M	USD	Annual
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-94.80M	USD	Annual
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.20B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.15B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$772.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$867.40M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of year (Note 5)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$772.60M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of year (Note 5)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$867.40M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of year (Note 5)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.15B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of year (Note 5)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.20B	USD	Point-in-time

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Common stock, beginning balance (in shares)	`CommonStockSharesOutstanding`	601.10M	shares	Point-in-time
Common stock, beginning balance (in shares)	`CommonStockSharesOutstanding`	608.30M	shares	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.72B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.57B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.84B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.81B	USD	Point-in-time
Treasury stock, beginning balance (in shares)	`TreasuryStockCommonShares`	38.00M	shares	Point-in-time
Treasury stock, beginning balance (in shares)	`TreasuryStockCommonShares`	49.40M	shares	Point-in-time
Net income (loss)	`ProfitLoss`	$1.52B	USD	Annual
Net income (loss)	`ProfitLoss`	$1.50B	USD	Annual
Net income (loss)	`ProfitLoss`	$1.40B	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-97.20M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$12.10M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$3.40M	USD	Annual
Common stock issued under equity plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$169.90M	USD	Annual
Common stock issued under equity plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$158.60M	USD	Annual
Common stock issued under equity plans	`StockIssuedDuringPeriodValueShareBasedCompensation`	$146.40M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$109.30M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$126.80M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$139.40M	USD	Annual
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$880.50M	USD	Annual
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$1.73B	USD	Annual
Purchases of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$512.80M	USD	Annual
Changes to noncontrolling interest (Note 9)	`MinorityInterestPeriodIncreaseDecrease`	$72.40M	USD	Annual
Common stock, ending balance (in shares)	`CommonStockSharesOutstanding`	601.10M	shares	Point-in-time
Common stock, ending balance (in shares)	`CommonStockSharesOutstanding`	608.30M	shares	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.72B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.57B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.84B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.81B	USD	Point-in-time
Treasury stock, ending balance (in shares)	`TreasuryStockCommonShares`	38.00M	shares	Point-in-time
Treasury stock, ending balance (in shares)	`TreasuryStockCommonShares`	49.40M	shares	Point-in-time

Comprehensive Income 27 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$1.52B	USD	Annual
Net income	`ProfitLoss`	$1.50B	USD	Annual
Net income	`ProfitLoss`	$1.40B	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-46.30M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.30M	USD	Annual
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-50.10M	USD	Annual
Unrealized (loss) gain on hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-23.10M	USD	Annual
Unrealized (loss) gain on hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$57.40M	USD	Annual
Unrealized (loss) gain on hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-5.90M	USD	Annual
Unrealized pension (costs) credits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-11.60M	USD	Annual
Unrealized pension (costs) credits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$9.90M	USD	Annual
Unrealized pension (costs) credits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-13.70M	USD	Annual
Unrealized gain (loss) on available-for-sale investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$40.80M	USD	Annual
Unrealized gain (loss) on available-for-sale investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-15.50M	USD	Annual
Unrealized gain (loss) on available-for-sale investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-58.70M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-97.20M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$12.10M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$3.40M	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.42B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.51B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.41B	USD	Annual
Comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	Annual
Comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-3.00M	USD	Annual
Comprehensive loss attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	-	USD	Annual
Comprehensive income attributable to Edwards Lifesciences Corporation	`ComprehensiveIncomeNetOfTax`	$1.42B	USD	Annual
Comprehensive income attributable to Edwards Lifesciences Corporation	`ComprehensiveIncomeNetOfTax`	$1.41B	USD	Annual
Comprehensive income attributable to Edwards Lifesciences Corporation	`ComprehensiveIncomeNetOfTax`	$1.51B	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.